Cargando…
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab
OBJECTIVE: To examine associations of body mass index (BMI), subcutaneous fat area (SFA) and density (SFD), visceral fat area (VFA) and density (VFD) and total psoas area (TPA) to outcomes among patients receiving chemotherapy with or without bevacizumab for advanced or recurrent endometrial cancer...
Autores principales: | Gillen, J., Mills, K.A., Dvorak, J., Zheng, B., Thai, T., Salani, R., Cosgrove, C.M., Davidson, B., Thaker, P.H., Moore, K.N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838799/ https://www.ncbi.nlm.nih.gov/pubmed/31720357 http://dx.doi.org/10.1016/j.gore.2019.100502 |
Ejemplares similares
-
The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020) -
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
por: Mills, Kathryn A., et al.
Publicado: (2019) -
PARPi after PARPi in epithelial ovarian cancer
por: Essel, K.G., et al.
Publicado: (2021) -
Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma
por: Wasilewski, Andrea, et al.
Publicado: (2018) -
Postablation Endometrial Carcinoma
por: Wortman, Morris, et al.
Publicado: (2017)